[Characteristics of immune complexes in myocardial infarct].
Nonspecific circulating immune complexes (CIC), different in size and stability, are detectable in the blood sera of patients with myocardial infarction; changed concentration of these complexes appears to be a reflection of the defense response of the body, aimed at homeostasis maintenance. No relationship between cardiac glycosides and CIC levels was revealed in patients with myocardial infarction. A reduction of the level of 'large' CICs by days 21-30 of the condition was observed in the patients treated with anticoagulants from the first day of the disease. A low CIC level in the acute period of the disease is a prognostically unfavorable sign in respect of the outcome of the condition.
Korochkin
E M
EM
Chukaeva
I I
II
Litvinova
S N
SN
Klebanov
G I
GI
Kreĭnina
M V
MV
Cherniak
V Ia
VIa
D000925:Anticoagulants / Q000494:pharmacology / Q000627:therapeutic use; D000936:Antigen-Antibody Complex / Q000032:analysis*; D002301:Cardiac Glycosides / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy / Q000276:immunology*; D011379:Prognosis; D013997:Time Factors
D000925:Anticoagulants; D000936:Antigen-Antibody Complex; D002301:Cardiac Glycosides
Osobennosti immunokompleksnogo protsessa pri infarkte miokarda.